The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Multicenter, Double-Blind, Placebo-Controlled Study of Mecamylamine Monotherapy for Tourette's Disorder
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mecamylamine does not appear to be effective as a monotherapy”
From Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders (2013) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606003-00015 · Cited by 1,440
Self-citationHulihan-Giblin, B. A., Lumpkin, M. D., & Kellar, K. J. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13322-3 · Cited by 77
Shytle, R. D., Silver, A. A., & Sanberg, P. R. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00945-8 · Cited by 41
Self-citation
Research works printed but not linked: 36
- Banerjee, 1990, [3H]Mecamylamine binding to rat brain membranes: studies with mecamylamine and nicotine analogues, Biochem Pharmacol, 40, 2105, 10.1016/0006-2952(90)90241-C · DOI
- Budman, 1998, Rage attacks in children and adolescents with Tourette's disorder: a pilot study, J Clin Psychiatry, 59, 576, 10.4088/JCP.v59n1103 · DOI
- Chappell, 1997, Future therapies of Tourette syndrome, Neurol Clin, 15, 429, 10.1016/S0733-8619(05)70324-8 · DOI
- Coffey, 2000, Distinguishing illness severity from tic severity in children and adolescents with Tourette's disorder, J Am Acad Child Adolesc Psychiatry, 39, 556, 10.1097/00004583-200005000-00008 · DOI
- Coffey, 1997, Behavioral and emotional aspects of Tourette syndrome, Neurol Clin, 15, 277, 10.1016/S0733-8619(05)70312-1 · DOI
- Collins, 1996, Long-term ethanol and nicotine treatment elicit tolerance to ethanol, Alcohol Clin Exp Res, 20, 990, 10.1111/j.1530-0277.1996.tb01936.x · DOI
- Dursun, 1995, Differential effects of transdermal nicotine patch on the symptoms of Tourette's syndrome, Br J Clin Pharmacol, 39, 100P
- Dursun, 1997, Differential effects of transdermal nicotine on microstructured analyses of tics in Tourette's syndrome: an open study, Psychol Med, 27, 483, 10.1017/S0033291796003984 · DOI
- Dursun, 1994, Longlasting improvement of Tourette's syndrome with transdermal nicotine (letter), Lancet, 344, 1577, 10.1016/S0140-6736(94)90388-3 · DOI
- Fulop, 1987, ECG changes during haloperidol and pimozide treatment of Tourette's disorder, Am J Psychiatry, 144, 673, 10.1176/ajp.144.5.673 · DOI
- Goetz, 1992, Clonidine and clonazepam in Tourette syndrome, Adv Neurol, 58, 245
- Goyette, 1978, Normative data on revised Conners Parent and Teacher Rating Scales, J Abnorm Child Psychol, 6, 221, 10.1007/BF00919127 · DOI · Paper page
- Horrigan, 1999, Guanfacine and secondary mania in children, J Affect Disord, 54, 309, 10.1016/S0165-0327(98)00183-9 · DOI
- Leckman, 1991, Clonidine treatment of Gilles de la Tourette's syndrome, Arch Gen Psychiatry, 48, 324, 10.1001/archpsyc.1991.01810280040006 · DOI · Paper page
- Leckman, 1989, The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity, J Am Acad Child Adolesc Psychiatry, 28, 566, 10.1097/00004583-198907000-00015 · DOI · Paper page
- Levin, 1999, Mutually potentiating effects of mecamylamine and haloperidol in producing catalepsy in rats, Drug Dev Res, 47, 90, 10.1002/(SICI)1098-2299(199906)47:2<90::AID-DDR4>3.0.CO;2-5 · doi:10.1002/(sici)1098-2299(199906)47:2<90::aid-ddr4>3.0.co;2-5
- Lukas, 1996, Regulation by nicotine of its own receptors, Drug Dev Res, 38, 136, 10.1002/(SICI)1098-2299(199607/08)38:3/4<136::AID-DDR2>3.0.CO;2-N · DOI
- Martin, 1993, Central actions of nicotine antagonists, Med Chem Res, 2, 564
- McConville, 1992, The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in reducing tic severity and frequency in Tourette's disorder, Biol Psychiatry, 31, 832, 10.1016/0006-3223(92)90315-Q · DOI
- Nolan, 1996, Associated psychopathology in children with both ADHD and chronic tic disorder, J Am Child Adolesc Psychiatry, 35, 1622, 10.1097/00004583-199612000-00014 · DOI
- Roth, 1972, Studies in the classification of affective disorders: the relationship between anxiety states and depressive illnesses, I, Br J Psychiatry, 121, 147, 10.1192/bjp.121.2.147 · DOI · Paper page
- Sanberg, 1989, Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome, Biomed Pharmacother, 43, 19, 10.1016/0753-3322(89)90186-8 · DOI
- Sanberg, 1998, Treatment of Tourette's syndrome with mecamylamine (letter), Lancet, 352, 705, 10.1016/S0140-6736(05)60822-7 · DOI
- Sanberg, 1997, Nicotine for the treatment of Tourette's syndrome, Pharmacol Ther, 74, 21, 10.1016/S0163-7258(96)00199-4 · DOI
- Sandor, 1990, Tourette syndrome: a follow-up study, J Clin Psychopharmacol, 10, 197, 10.1097/00004714-199006000-00007 · DOI
- Shapiro, 1989, Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette's syndrome, Arch Gen Psychiatry, 46, 722, 10.1001/archpsyc.1989.01810080052006 · DOI · Paper page
- Sheehan, 1998, The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10., J Clin Psychiatry, 59, 22
- Shytle, 1996, Transdermal nicotine for Tourette's syndrome, Drug Dev Res, 38, 290, 10.1002/(SICI)1098-2299(199607/08)38:3/4<290::AID-DDR18>3.0.CO;2-2 · DOI
- Silva, 1996, Causes of haloperidol discontinuation in patients with Tourette's disorder: management and alternatives, J Clin Psychiatry, 57, 129
- Silver, 1996, Case study: long-term potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome, J Am Acad Child Adolesc Psychiatry, 35, 1631, 10.1097/00004583-199612000-00015 · DOI
- Silver, 1999, Clinical experience with transdermal nicotine patch in Tourette's syndrome, CNS Spectr, 4, 68, 10.1017/S1092852900011408 · DOI
- Silver, 2000, Mecamylamine in Tourette's syndrome: a two-year retrospective case, J Child Adolesc Psychopharmacol, 10, 59, 10.1089/cap.2000.10.59 · DOI
- Silver AA, Shytle RD, Wilkinson B, McConville B, Sanberg PR (in press), Transdermal nicotine and haloperidol in Tourette syndrome: a double-blind placebo controlled study. J Clin Psychiatry
- Singer, 1989, Development of behavioral and emotional problems in Tourette syndrome, Pediatr Neurol, 5, 41, 10.1016/0887-8994(89)90008-8 · DOI
- Spencer, 1998, Disentangling the overlap between Tourette's disorder and ADHD, J Child Psychol Psychiatry, 39, 1037, 10.1111/1469-7610.00406 · doi:10.1111/1469-7610.00406 · Paper page
- Stone, 1956, Ganglionic blocking properties of 3-methylaminoisocamphane hydrochloride (mecamylamine): a secondary amine, J Pharmacol, 117, 169
Cited by
Leckman, J. F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11526-1 · Cited by 685
Contemporary assessment and pharmacotherapy of Tourette syndrome
Scahill, L., Erenberg, G., Berlin, C. M., Budman, C., Coffey, B. J., Jankovic, J., Kiessling, L., King, R. A., Kurlan, R., Lang, A., et al. (2006) · NeuroRX · doi:10.1016/j.nurx.2006.01.009 · Cited by 300
Nicotinic acetylcholine receptors as targets for antidepressants
Shytle, R. D., Silver, A. A., Lukas, R. J., Newman, M. B., Sheehan, D. V., & Sanberg, P. R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001035 · Cited by 279
Self-citationNicotine receptors and depression: revisiting and revising the cholinergic hypothesis
Mineur, Y. S., & Picciotto, M. R. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.09.004 · Cited by 279
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders
Murphy, T. K., Lewin, A. B., Storch, E. A., & Stock, S. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.09.015 · Cited by 276
Metadata
- Authors
- SILVER, A. A., SHYTLE, R. D., SHEEHAN, K. H., SHEEHAN, D. V., RAMOS, A., & SANBERG, P. R.
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 2001-09
- Volume
- 40
- Issue
- 9
- Pages
- 1103-1110
- ISSN
- 0890-8567
- Cited by
- 90
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multicenter, Double-Blind, Placebo-Controlled Study of Mecamylamine Monotherapy for Tourette's Disorder. https://app.cochat.ai/papers/10.1097/00004583-200109000-00020
- The paper
- SILVER, A. A., SHYTLE, R. D., SHEEHAN, K. H., SHEEHAN, D. V., RAMOS, A., & SANBERG, P. R. (2001). Multicenter, Double-Blind, Placebo-Controlled Study of Mecamylamine Monotherapy for Tourette's Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. https://doi.org/10.1097/00004583-200109000-00020
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.